<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "https://jats.nlm.nih.gov/publishing/1.4/JATS-journalpublishing1-4.dtd">
<article article-type="case-report" dtd-version="1.4" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">odmj</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">OncoDaily Medical Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">ODMJ</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">3067-6444</issn>
      <publisher>
        <publisher-name>OncoDaily Medical Journal</publisher-name>
        <publisher-loc>
          <country>US</country>
        </publisher-loc>
      </publisher>
      <self-uri xlink:href="https://oncodailyjournal.com/"/>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">7452</article-id>
      <article-id pub-id-type="doi">10.69690/ODMJ-011-0426-7452</article-id>
      <article-categories>
        <subj-group xml:lang="en" subj-group-type="heading">
          <subject>Case Reports &amp;amp; Case Series</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Double Dilemma: Managing a Sequential Lymphoma (Case Report)</article-title>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Alidina</surname>
            <given-names>Zayan</given-names>
          </name>
          <aff xml:lang="en">Department of Oncology, Aga Khan University Hospital, Karachi, Pakistan</aff>
          <email>zayan.alidina@scholar.aku.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nasir</surname>
            <given-names>Saad</given-names>
          </name>
          <aff xml:lang="en">Medical College, Aga Khan University, Karachi 74800, Pakistan</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ahmed</surname>
            <given-names>Faiza</given-names>
          </name>
          <aff xml:lang="en">Medical College, Aga Khan University, Karachi 74800, Pakistan</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moosajee</surname>
            <given-names>Munira</given-names>
          </name>
          <aff xml:lang="en">Medical College, Aga Khan University, Karachi 74800, Pakistan</aff>
        </contrib>
      </contrib-group>
      <pub-date date-type="pub" publication-format="electronic">
        <day>12</day>
        <month>04</month>
        <year>2026</year>
      </pub-date>
      <elocation-id>ODMJ-011-0426-7452</elocation-id>
      <permissions>
        <copyright-statement>Copyright (c) 2026 OncoDaily Medical Journal</copyright-statement>
        <copyright-year>2026</copyright-year>
        <copyright-holder>OncoDaily Medical Journal</copyright-holder>
      </permissions>
      <self-uri xlink:href="https://oncodailyjournal.com/10.69690/odmj-011-0426-7452/"/>
      <kwd-group xml:lang="en">
        <kwd>Case Reports</kwd>
        <kwd>DLBCL</kwd>
        <kwd>OncoDaily Medical Journal</kwd>
        <kwd>Sequential Lymphoma</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>production-ready-file-url</meta-name>
          <meta-value>
            <ext-link ext-link-type="uri" xlink:href="https://oncodailyjournal.com/pub/uploads/2026/04/10.69690ODMJ-011-0426-7452.pdf"/>
          </meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body/>
  <back>
    <ref-list>
      <ref id="R1">
        <mixed-citation>Jamil A, Mukkamalla SKR. Lymphoma. StatPearls. 2023 Jul 17.</mixed-citation>
      </ref>
      <ref id="R2">
        <mixed-citation>Liu W, Liu J, Song Y, Wang X, Mi L, Cai C, et al. Burden of lymphoma in China, 1990-2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019. Aging (Albany NY). 2022;14(7):3175.</mixed-citation>
      </ref>
      <ref id="R3">
        <mixed-citation>Aussedat G, Traverse-Glehen A, Stamatoullas A, Molina T, Safar V, Laurent C, et al. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases. Br J Haematol. 2020;189(2):244-56.</mixed-citation>
      </ref>
      <ref id="R4">
        <mixed-citation>Eyre TA, Gatter K, Collins GP, Hall GW, Watson C, Hatton CSR. Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant hodgkin lymphoma: Long-term outcomes from a 30-year experience. Am J Hematol. 2015;90(6):E103-E110.</mixed-citation>
      </ref>
      <ref id="R5">
        <mixed-citation>Tao Y, Chen H, Liu D, Dai X. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study. Leuk Res. 2021;111.</mixed-citation>
      </ref>
      <ref id="R6">
        <mixed-citation>Balodis A, Anna Pimenova D, Sergey Nikulshin EF, Ginta Balode EF, Hasnere S. Rare Case of Hodgkin Lymphoma Transformation into Diffuse Large B-Cell Lymphoma with Atypical Spread Epidurally, Intradurally and Intramedullary: A Case Report. Am J Case Rep. 2022;23(1):e935014-1.</mixed-citation>
      </ref>
      <ref id="R7">
        <mixed-citation>Küppers R. The biology of Hodgkin’s lymphoma. Nature Reviews Cancer 2009 9:1. 2008;9(1):15-27.</mixed-citation>
      </ref>
      <ref id="R8">
        <mixed-citation>Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma. Blood. 2018;131(21):2307-2319.</mixed-citation>
      </ref>
      <ref id="R9">
        <mixed-citation>Coleman R, Zhou Y, Chan A. Adjuvant denosumab in early breast cancer – Authors’ reply. Lancet Oncol. 2020;21(3):e125.</mixed-citation>
      </ref>
      <ref id="R10">
        <mixed-citation>Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800-1808.</mixed-citation>
      </ref>
      <ref id="R11">
        <mixed-citation>Telio D, Fernandes K, Ma C, et al. Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors. Leuk Lymphoma. 2012;53(5):836-841.</mixed-citation>
      </ref>
      <ref id="R12">
        <mixed-citation>Tun AM, Wang Y, Maliske S, et al. Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy. Transplant Cell Ther. 2024;30(10):1001.e1-1001.e12.</mixed-citation>
      </ref>
      <ref id="R13">
        <mixed-citation>Henriksen PA. Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention. Heart. 2018;104(12):971-977.</mixed-citation>
      </ref>
      <ref id="R14">
        <mixed-citation>Chu DT, Nguyen TT, Tien NLB, et al. Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications. Cells. 2020;9(3).</mixed-citation>
      </ref>
      <ref id="R15">
        <mixed-citation>Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354(17):1813-1826.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
